CNS vs BAM
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 12, 2026
CNS
BAM
Investment Advisor Scores
BAM
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CNS | BAM | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 19.084 | 21.5517 | CNS |
| PEG Ratio | 1.7476 | 1.0465 | BAM |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 12.2% | 60.8% | BAM |
| Earnings Growth | 31.9% | 47.4% | BAM |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 51.9/100 | 49.1/100 | CNS |
| Profit Margin | 28.8% | 48.9% | BAM |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CNS
NeutralMixed signals - no dominant trend phase, RSI 33
BAM
NeutralMixed signals - no dominant trend phase, RSI 35
Fundamentals Snapshot
| Metric | CNS | BAM |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 18.8 | 21.8 |
| Trailing P/E | 23.7 | 27.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.6% |
| Gross Margin | 0.5% | 0.7% |
| Operating Margin | 0.3% | 0.7% |
| EPS | 3.23 | 1.72 |
| Dividend Yield | 0.03% | 0.04% |